The millennial-skewed telehealth platform Hims & Hers (HIMS) announced Monday that it will start offering customers a generic version of liraglutide, an older GLP-1 weight loss drug, next year. The ...
The new contract will establish new standards that may be used to enhance specificity and sensitivity across industry assay ...
5d
We recently compiled a list of the 10 Best S&P 500 Stocks to Buy According to Hedge Funds. In this article, we are going to ...
We recently published a list of 10 Stocks To Buy Before They Split Next. In this article, we are going to take a look at ...
As weight-loss injections emerge as key players in the government’s anti-obesity strategy, Emma Loffhagen goes inside the ...
Munjaro and Ozempic have emerged as useful tools for weight loss, particularly for people dealing with obesity or type 2 ...
As the demand for weight loss injectables soars, so too does the market for off-brand alternatives, some of which may not be ...
As obesity rates in the United States soar, insurance companies, including Medicaid and Medicare, are facing financial ...
Novo Nordisk has asked the FDA to block production of compounded copies of Ozempic, arguing that it’s too difficult to do ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback